Magnetar Financial LLC Horizon Therapeutics Public LTD CO Transaction History

Magnetar Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $15.4 Million - $18 Million	-155,535 Reduced 25.53%	453,622 $52.5 Million
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $12.2 Million - $14.2 Million	-126,296 Reduced 17.17%	609,157 $62.7 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $5.11 Million - $5.4 Million	-47,612 Reduced 6.08%	735,453 $80.3 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $48.9 Million - $89.1 Million	783,065 New	783,065 $89.1 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $3.67 Million - $5.38 Million	46,264 Added 15.59%	342,941 $27.4 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $11.3 Million - $14.4 Million	130,916 Added 78.98%	296,677 $31.2 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $16.3 Million - $19.9 Million	165,761 New	165,761 $17.9 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $7.61 Million - $10.1 Million	-106,012 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $7.1 Million - $8.95 Million	106,012 New	106,012 $7.76 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.